Associations Between Neurobehavioral Symptoms During Breast Cancer Chemotherapy and Patient‐Reported Cognitive Impairment 3 or More Years After Chemotherapy
Patient-reported neurobehavioral symptoms experienced during chemotherapy, including depression, anxiety, and fatigue, were associated with patient-reported CRCI years after primary treatment and should be monitored for timely intervention opportunities.
Authors
- Sarah L. Laughon (ORCID: https://orcid.org/0000-0001-7405-8748)
- K. A. NYROP
- Alexis C. Wardell (ORCID: https://orcid.org/0000-0003-1413-3464)
- Jared D. Smith
- Allison M. Deal
- Hyman B. Muss
Institutions
- University of North Carolina at Chapel Hill (US)
- Campbell University (US)
Publication Details
- Journal
- Psycho-Oncology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1002/pon.70411
- Primary Topic
- Cancer-related cognitive impairment studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Breast Cancer Research Foundation
- Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill